TABLE 1.

Characteristics of patients

Patient no.	Age (yr)	Genderb	Treatment at surgery		Sputumd		Indication for surgery	Macroscopic descriptione	Caseationf	Cavitationf	Fibrosisf
			Drugsc	Mo	Smear	Culture
1	19	F	R H Z E S	18	Pos	Pos	Persistent TB	Destroyed L lung	Y	Y	Y
2a	17	M	R H Z E S Et Th Km Of	18	Pos	Pos	Persistent TB	Destroyed R lung	Y	Y	Y
3a	35	M	R H Z E Et Th Km Of Cl	24	Pos	Pos	Persistent TB	Destroyed L lung	Y	Y	Y
4	54	M	R H Z E	7	Neg	Neg	Hemoptysis	Destroyed L lung	N	Y	Y
5	59	F	R H Z E	9	Neg	Neg	Hemoptysis	Destroyed L lung	N	Y	Y
6	45	M	R H Z E	15	Neg	Neg	Hemoptysis	Destroyed L lung	N	Y	Y

^aMDR TB.

^bM, male; F, female.

^cR, rifampin; H, isoniazid; Z, pyrazinamide; E, ethambutol; S, streptomycin; E, ethionamide; Th, thiacetazone; Km, kanamycin; Of, ofloxacin; Cl, clofazamine.

^dAt the time of surgery. Pos, positive; Neg, negative.

^eR, right; L, left.

^fY, yes; N, no.